FDA Investigator: Xiaokuang Lai
- Xiaokuang Lai first started conducting FDA inspections in 2002, with the last inspection in 2024. Over that time, Xiaokuang Lai has conducted 50 inspections at 40 companies across 48 sites.
Get Xiaokuang Lai's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Laboratorio Reig Jofre, Toledo | June 2023
Available Now - $199
Xiaokuang Lai
Human Drugs Form 483
FDA 483 Haupt Pharma Wolfratshausen, Wolfratshausen | 2022
Available Now - $199
Xiaokuang Lai
Human Drugs Form 483
FDA 483 Emcure Pharmaceuticals Limited, Charal | 2024
Out-of-stock
Xiaokuang Lai
Human Drugs Form 483
FDA 483 Steriscience Specialties Private Limited, Bengaluru | 2024
Out-of-stock
Xiaokuang Lai
Human Drugs Form 483
FDA 483 Steriscience SP. Z O.O., Warsaw | 2023
Out-of-stock
Xiaokuang Lai
Human Drugs Form 483
FDA 483 Solvias AG, Kaiseraugst | 2022
Out-of-stock
Xiaokuang Lai
Human Drugs Form 483
FDA 483 Aurobindo Pharma Ltd, Bachupally | 2020
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
FDA 483 Genzyme Polyclonals S.A.S., Lyon | 2018
Out-of-stock
Xiaokuang Lai
Biologic Form 483
FDA 483 Ipsen BioPharm Ltd, Wrexham | 2018
Out-of-stock
Xiaokuang Lai
Biologic Form 483
FDA 483 BSP Pharmaceuticals Srl, Latina | 2016
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
FDA 483 Janssen Pharmaceutica NV, Beerse | 2016
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
FDA 483 KYJ Medical Products Co., Ltd., Changzhou | 2015
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
FDA 483 Hainan Hailing Chemipharma Corporation Limited, Haikou | 2015
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
FDA 483 Fresenius Kabi Austria Gmbh, Graz | 2015
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
FDA 483 Pierre Fabre Medicament Production, Idron | 2015
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
FDA 483 Impax Laboratories (Taiwan) Inc., Jhunan, Miao-Li County | 2014
Out-of-stock
Xiaokuang Lai
Human Drug Form 483
Co-Investigators (45)
- Kellia N. Hicks, FDA Investigator
- Jeffrey P. Raimondi, FDA Investigator
- Pratik S. Upadhyay, FDA Investigator
- Anastasia M. Shields, FDA Investigator
- Guerlain Ulysse, FDA Investigator
- Frederick Razzaghi, FDA Investigator
- Arie Menachem, FDA Investigator
- Anita Narula, FDA Investigator
- Christopher D. Leach, FDA Investigator
- Francis A. Guidry, FDA Investigator
- Libia M. Lugo, FDA Investigator
- Jose A. Cruz Gonzalez, FDA Investigator
- Cruz Gonzalez, Jose A, FDA Investigator
- Katherine E. Jacobitz, FDA Investigator
- Michele Perry-Williams, FDA Investigator
- Michele Perry Williams, FDA Investigator
- Christina A. Capacci-Daniel, FDA Investigator
- Seneca D. Toms, FDA Investigator
- Thomas A. Peter, FDA Investigator Medical Device Specialist
- Regina T. Brown, FDA Investigator
- Kalavati C. Suvarna, FDA Investigator
- Nicholas A. Violand, FDA Investigator
- Charisse K. Green, FDA Investigator
- Robert C. Steyert, FDA Investigator
- Kazi Rafiquzzaman, FDA Investigator
- Ivis L. Negron Torres, FDA Investigator
- Negron Torres, Ivis L, FDA Investigator
- Mihaly S. Ligmond, FDA Investigator
- Ramon E. Martinez, FDA Investigator
- Megan A. Haggerty, FDA Investigator
- Amy C. Jordan, FDA Investigator
- Amy W. Yan Mai, FDA Investigator
- Evelyn Taha, FDA Investigator
- Yan Mai, Amy W, FDA Investigator
- Kenneth G. Klobus, FDA Investigator
- Manhar R. Patel, FDA Investigator
- Daniel L. Aisen, FDA Investigator
- Joy P. Matthias, FDA Investigator
- Sarah A. Meehan, FDA Investigator
- Joyce A. Williams, FDA Investigator
- Paul C. Mouris, FDA Investigator
- Gary J. Lehr, FDA Investigator
- Parul M. Patel, FDA Investigator
- Donald J. Ullstrom, FDA Investigator
- Morris Paul, FDA Investigator